Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Operating Leases (2022 - 2023)

Historic Operating Leases for Cullinan Therapeutics (CGEM) over the last 2 years, with Q3 2023 value amounting to $2.4 million.

  • Cullinan Therapeutics' Operating Leases fell 3872.75% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 million, marking a year-over-year decrease of 3872.75%. This contributed to the annual value of $3.6 million for FY2022, which is N/A changed from last year.
  • Cullinan Therapeutics' Operating Leases amounted to $2.4 million in Q3 2023, which was down 3872.75% from $2.7 million recorded in Q2 2023.
  • Cullinan Therapeutics' Operating Leases' 5-year high stood at $4.0 million during Q3 2022, with a 5-year trough of $596000.0 in Q2 2022.